Table of Contents
Chapter 1 Cancer Biopsy Market: Research Methodology And Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Type Segment
1.1.1.3 Application Segment
1.1.1.4 End Use Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Cancer Biopsy Market: Executive Summary
2.1 Market Outlook
2.2 Product And Type Snapshot
2.3 Application Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Cancer Biopsy Market: Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Advent Of Liquid Biopsy
3.2.1.2 Transition Of Novel Oncology Diagnostics From Bench To Clinics
3.2.1.3 Advancements In Quality And Payment Pertaining To Genetic Cancer Tests
3.2.2 Market Restraint Analysis
3.2.2.1 Risks Associated With Biopsy Procedures
3.2.2.2 Technical And Clinical Challenges
3.3 Industry Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Pestel Analysis
Chapter 4 Cancer Biopsy Market: Product Business Analysis
4.1 Cancer Biopsy Market: Product Movement Analysis
4.2 Instruments
4.2.1 Instruments Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3 Kits And Consumabkes
4.3.1 Kits And Consumabels Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.4 Services
4.4.1 Services Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 5 Cancer Biopsy Market: Type Business Analysis
5.1 Cancer Biopsy Market: Type Movement Analysis
5.2 Tissue Biopsies
5.2.1 Tissue Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2 Needle Biopsies
5.2.2.1 Needle Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2.2 Fine Needle Aspiration (Fna)
5.2.2.2.1 Fine Needle Aspiration (Fna) Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.2.3 Core Needle Biopsy (Cnb)
5.2.2.3.1 Core Needle Biopsy (Cnb) Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.2.3 Surgical Biopsies
5.2.3.1 Surgical Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3 Liquid Biopsies
5.3.1 Liquid Biopsies Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.4 Others
5.4.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Cancer Biopsy Market: Application Business Analysis
6.1 Cancer Biopsy Market: Application Movement Analysis
6.2 Breast Cancer
6.2.1 Breast Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3 Colorectal Cancer
6.3.1 Colorectal Cancer Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.4 Cervical Cancers
6.4.1 Cervical Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.5 Lung Cancers
6.5.1 Lung Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Prostate Cancers
6.6.1 Prostate Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Skin Cancers
6.7.1 Skin Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.8 Blood Cancers
6.8.1 Blood Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.9 Kidney Cancers
6.9.1 Kidney Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.10 Liver Cancers
6.10.1 Liver Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.11 Pancreatic Cancers
6.11.1 Pancreatic Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.12 Ovarian Cancers
6.12.1 Ovarian Cancers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.13 Others
6.13.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Cancer Biopsy Market: Regional Business Analysis
7.1 Regional Market Snapshot
7.2 North America
7.2.1 North America Cancer Biopsy Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.2.2.2 Key Country Dynamics
7.2.2.3 Regulatory Framework
7.2.2.4 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Canada Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.2.3.2 Key Country Dynamics
7.2.3.3 Regulatory Framework
7.2.3.4 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.2 Uk
7.3.2.1 Uk Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.2.2 Key Country Dynamics
7.3.2.3 Regulatory Framework
7.3.2.4 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Germany Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.3.2 Key Country Dynamics
7.3.3.3 Regulatory Framework
7.3.3.4 Reimbursement Scenario
7.3.4 Spain
7.3.4.1 Spain Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.4.2 Key Country Dynamics
7.3.4.3 Regulatory Framework
7.3.4.4 Reimbursement Scenario
7.3.5 France
7.3.5.1 France Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.5.2 Key Country Dynamics
7.3.5.3 Regulatory Framework
7.3.5.4 Reimbursement Scenario
7.3.6 Italy
7.3.6.1 Italy Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.6.2 Key Country Dynamics
7.3.6.3 Regulatory Framework
7.3.6.4 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Denmark Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.7.2 Key Country Dynamics
7.3.7.3 Regulatory Framework
7.3.7.4 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Sweden Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.8.2 Key Country Dynamics
7.3.8.3 Regulatory Framework
7.3.8.4 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Norway Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.3.9.2 Key Country Dynamics
7.3.9.3 Regulatory Framework
7.3.9.4 Reimbursement Scenario
7.4 Asia Pacific
7.4.1 Asia-Pacific Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.2.2 Key Country Dynamics
7.4.2.3 Regulatory Framework
7.4.2.4 Reimbursement Scenario
7.4.3 China
7.4.3.1 China Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.3.2 Key Country Dynamics
7.4.3.3 Regulatory Framework
7.4.3.4 Reimbursement Scenario
7.4.4 India
7.4.4.1 India Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.4.2 Key Country Dynamics
7.4.4.3 Regulatory Framework
7.4.4.4 Reimbursement Scenario
7.4.5 South Korea
7.4.5.1 South Korea Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.5.2 Key Country Dynamics
7.4.5.3 Regulatory Framework
7.4.5.4 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Thailand Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.6.2 Key Country Dynamics
7.4.6.3 Regulatory Framework
7.4.6.4 Reimbursement Scenario
7.4.7 Australia
7.4.7.1 Australia Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.4.7.2 Key Country Dynamics
7.4.7.3 Regulatory Framework
7.4.7.4 Reimbursement Scenario
7.5 Latin America
7.5.1 Latin America Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.2.2 Key Country Dynamics
7.5.2.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.3 Mexico
7.5.3.1 Mexico Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.3.2 Key Country Dynamics
7.5.3.3 Regulatory Framework
7.5.2.4 Reimbursement Scenario
7.5.4 Argentina
7.5.4.1 Argentina Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.5.4.2 Key Country Dynamics
7.5.4.3 Regulatory Framework
7.5.4.4 Reimbursement Scenario
7.6 MEA
7.6.1 MEA Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.2.2 Key Country Dynamics
7.6.2.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.3.2 Key Country Dynamics
7.6.3.3 Regulatory Framework
7.6.3.4 Reimbursement Scenario
7.6.4 Uae
7.6.4.1 Uae Cancer Biopsy Market, 2018 – 2030 (USD Million)
7.6.4.2 Key Country Dynamics
7.6.4.3 Regulatory Framework
7.6.2.4 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Kuwait Cancer Biopsy Market, 2018 – 2030 (USD MILLION)
7.6.5.2 Key Country Dynamics
7.6.5.3 Regulatory Framework
7.6.5.4 Reimbursement Scenario
Chapter 8 Cancer Biopsy Market: Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New product launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 QIAGEN
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 ILLUMINA, INC.
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 ANGLE PLC
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 BD (BECTON, DICKINSON AND COMPANY)
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 MYRIAD GENETICS
8.4.5.1 Company overview
8.4.5.1.1 Counsyl, Inc.
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 HOLOGIC, INC.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.7 BIOCEPT, INC.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 THERMO FISHER SCIENTIFIC, INC.
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
9.4.9 DANAHER
8.4.9.1 Company overview
8.4.9.2 Beckman Coulter, Inc
8.4.9.3 Radiometer Medical ApS
8.4.9.4 HemoCue AB
8.4.9.5 Financial performance
8.4.9.6 Product benchmarking
8.4.10 F. HOFFMANN-LA ROCHE LTD.
8.4.10.1 Company overview
8.4.10.2 FOUNDATION MEDICINE, INC.
8.4.10.3 Financial performance
8.4.10.4 Product benchmarking
8.4.11 LUCENCE DIAGNOSTICS PTE. LTD.
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.11.4 Strategic initiatives
8.4.12 GRAIL, INC.
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 GUARDANT HEALTH
8.4.13.1 Company overview
8.4.13.2 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
8.4.14 EXACT SCIENCES CORPORATION
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 FREENOME HOLDINGS, INC.
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
8.4.16 BIODESIX (INTEGRATED DIAGNOSTICS)
8.4.16.1 Company overview
8.4.16.2 Financial performance
8.4.16.3 Product benchmarking
8.4.16.4 Strategic initiatives
8.4.17 ONCIMMUNE
8.4.17.1 Company overview
8.4.17.2 Financial performance
8.4.17.3 Product benchmarking
8.4.17.4 Strategic initiatives
8.4.18 EPIGENOMICS AG.
8.4.18.1 Company overview
8.4.18.2 Financial performance
8.4.18.3 Product benchmarking
8.4.18.4 Strategic initiatives
8.4.19 HELIOHEALTH (LABORATORY FOR ADVANCED MEDICINE)
8.4.19.1 Company overview
8.4.19.2 Financial performance
8.4.19.3 Product benchmarking
8.4.19.4 Strategic initiatives
8.4.20 GENESYSTEMS, INC. (GENESYS BIOLABS)
8.4.20.1 Company overview
8.4.20.2 Financial performance
8.4.20.3 Product benchmarking
8.4.20.4 Strategic initiatives
8.4.21 CHRONIX BIOMEDICAL, INC.
8.4.21.1 Company overview
8.4.21.2 Financial performance
8.4.21.3 Product benchmarking
8.4.21.4 Strategic initiatives
8.4.22 PERSONAL GENOME DIAGNOSTICS INC.
8.4.22.1 Company overview
8.4.22.2 Financial performance
8.4.22.3 Product benchmarking
8.4.22.4 Strategic initiatives
8.4.23 NATERA, INC.
8.4.23.1 Company overview
8.4.23.2 Financial performance
8.4.23.3 Product benchmarking
8.4.23.4 Strategic initiatives
8.4.24 PERSONALIS INC.
8.4.16.1 Company overview
8.4.24.2 Financial performance
8.4.24.3 Product benchmarking
8.4.24.4 Strategic initiatives
Chapter 9 KOL Recommendations/Analyst Perspective
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 4 North America cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 5 North America cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 9 Canada cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 10 Canada cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 11 Canada cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 12 Europe cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 13 Europe cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 14 Europe cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 15 Germany cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 16 Germany cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 17 Germany cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 18 UK cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 19 UK cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 20 UK cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 21 France cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 22 France cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 23 France cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 24 Spain cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 25 Spain cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 26 Spain cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 27 Italy cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 28 Italy cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 29 Italy cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 30 Denmark cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 31 Denmark cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 32 Denmark cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 34 Sweden cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 36 Norway cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 37 Norway cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 38 Norway cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 40 Asia Pacific cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 42 Japan cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 43 Japan cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 44 Japan cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 45 China cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 46 China cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 47 China cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 48 India cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 49 India cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 50 India cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 51 South Korea cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 52 South Korea cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 53 South Korea cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 54 Thailand cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 55 Thailand cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 56 Thailand cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 57 Australia cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 58 Australia cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 59 Australia cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 60 Latin America cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 61 Latin America cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 62 Latin America cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 63 Brazil cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 64 Brazil cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 65 Brazil cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 66 Mexico cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 67 Mexico cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 68 Mexico cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 69 Argentina cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 70 Argentina cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 71 Argentina cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 72 MEA cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 73 MEA cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 74 MEA cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 75 South Africa cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 76 South Africa cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 77 South Africa cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 78 Saudi Arabia cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 81 UAE cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 82 UAE cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 83 UAE cancer biopsy market, by application, 2018 - 2030 (USD Million)
Table 84 Kuwait cancer biopsy market, by product, 2018 - 2030 (USD Million)
Table 85 Kuwait cancer biopsy market, by type, 2018 - 2030 (USD Million)
Table 86 Kuwait cancer biopsy market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Cancer biopsy market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Segment snapshot
Fig. 12 Competitive landscape
Fig. 13 Cancer Biopsy Market Value, 2022 (USD Billion)
Fig. 14 Cancer Biopsy - Industry value chain analysis
Fig. 15 Cancer biopsy market dynamics
Fig. 16 Cancer biopsy market: PORTER’s analysis
Fig. 17 Cancer biopsy market: PESTEL analysis
Fig. 18 Cancer biopsy market: By application: Key takeaways
Fig. 19 Cancer biopsy market, by application: Market share, 2022 & 2030
Fig. 20 Genetic disorders market, 2018 - 2030 (USD Million)
Fig. 21 Oncology market, 2018 - 2030 (USD Million)
Fig. 22 Personalized medicine market, 2018 - 2030 (USD Million)
Fig. 23 Other application market, 2018 - 2030 (USD Million)
Fig. 24 Cancer biopsy market: By product: Key takeaways
Fig. 25 Cancer biopsy market, by product: Market share, 2022 & 2030
Fig. 26 Instruments market, 2018 - 2030 (USD Million)
Fig. 27 Kits and consumables market, 2018 - 2030 (USD Million)
Fig. 28 Services market, 2018 - 2030 (USD Million)
Fig. 29 Cancer biopsy market: By type: Key takeaways
Fig. 30 Cancer biopsy market, by type: Market share, 2022 & 2030
Fig. 31 Tissue biopsies market, 2018 - 2030 (USD Million)
Fig. 32 Needle biopsies market, 2018 - 2030 (USD Million)
Fig. 33 Fine needle aspiration (FNA) market, 2018 - 2030 (USD Million)
Fig. 34 Core needle biopsy (CNB) market, 2018 - 2030 (USD Million)
Fig. 35 Surgical biopsies market, 2018 - 2030 (USD Million)
Fig. 36 Liquid biopsies market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 Cancer biopsy market: By application: Key takeaways
Fig. 39 Cancer biopsy market, by application: Market share, 2022 & 2030
Fig. 40 Breast cancer market, 2018 - 2030 (USD Million)
Fig. 41 Colorectal cancer market, 2018 - 2030 (USD Million)
Fig. 42 Cervical cancers market, 2018 - 2030 (USD Million)
Fig. 43 Lung cancers market, 2018 - 2030 (USD Million)
Fig. 44 Prostate cancer market, 2018 - 2030 (USD Million)
Fig. 45 Skin cancer market, 2018 - 2030 (USD Million)
Fig. 46 Blood cancers market, 2018 - 2030 (USD Million)
Fig. 47 Kidney cancers market, 2018 - 2030 (USD Million)
Fig. 48 Liver cancer market, 2018 - 2030 (USD Million)
Fig. 49 Pancreatic cancers market, 2018 - 2030 (USD Million)
Fig. 50 Ovarian cancers market, 2018 - 2030 (USD Million)
Fig. 51 Others market, 2018 - 2030 (USD Million)
Fig. 52 Cancer biopsy market revenue, by region, 2022 & 2030, (USD Million)
Fig. 53 Regional marketplace: Key takeaways
Fig. 54 Regional marketplace: Key takeaways
Fig. 55 North America: SWOT analysis
Fig. 56 North America cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Reimbursement procurement process
Fig. 59 U.S. cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Canada cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Europe: SWOT analysis
Fig. 63 Europe cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Germany cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 UK cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 France color-correcting classes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Italy cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Spain cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Denmark cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Sweden cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Norway cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Asia Pacific: SWOT analysis
Fig. 81 Asia Pacific cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Reimbursement procurement process
Fig. 84 Japan cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 China cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 India cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Australia cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 South Korea cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Thailand cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Latin America: SWOT analysis
Fig. 96 Latin America cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 Brazil cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Mexico cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Argentina cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 MEA: SWOT analysis
Fig. 104 Middle East & Africa cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 South Africa cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Saudi Arabia cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 UAE cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Kuwait cancer biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key company categorization
Fig. 114 Company market position analysis
Fig. 115 Strategic framework
